Marksans Pharma Ltd (BOM:524404) reported a strong revenue growth of 20.8% year-on-year for Q2 FY25, driven by robust performance in the US, Australia, and New Zealand markets. The US market saw a ...
Vaishali Parekh has recommended three stocks for today — Marksans Pharma, Deep Industries, and Alkem Laboratories.